Chimerism analysis has become an important tool for the peri-transplant surveillance of
engraftment. It offers the possibility to realize impending graft rejection and can serve as an …

This review highlights literature pertinent to chimerism analysis in the context of
hematopoietic cell transplantation (HCT). We also conducted a survey of testing practices of …

Allogeneic hematopoietic cell transplantation (allo-HCT) is potentially curative for certain
hematologic malignancies and nonmalignant diseases. The field of allo-HCT has witnessed …

Graft failure may contribute to increased morbidity and mortality after allogeneic
hematopoietic SCT (allo-HSCT). Here, we present risk factors for graft failure in all first allo …

We compared the results of chimerism analyses with real‐time SNP‐PCR to those obtained
by the classical STR‐PCR method in 135 hematopoietic stem cell transplantation recipients …

Analysis of hematopoietic chimerism after allogeneic stem cell transplantation represents a
crucial method to evaluate donor-cell engraftment. Whereas sensitivity of classical …

Chimerism testing after allogeneic hematopoietic stem cell transplantation (allo-HSCT) in
patients with acute myeloid leukemia (AML) and myelodysplastic syndromes (MDS) …

The value of prophylactic donor lymphocyte infusion (pDLI) is unclear and differs among
diseases and transplantation protocols. Experience with this approach in patients with acute …

Conventional analysis of host chimerism (HC) frequently fails to detect relapse before its
clinical manifestation in patients with hematological malignancies after allogeneic stem cell …

Little data are available on the relative merits of chimerism and minimal residual disease
(MRD) monitoring for relapse prediction after allogeneic hematopoietic stem cell …